[go: up one dir, main page]

EP2080502B1 - Dispositif d'emballage du type blister - Google Patents

Dispositif d'emballage du type blister Download PDF

Info

Publication number
EP2080502B1
EP2080502B1 EP08100536A EP08100536A EP2080502B1 EP 2080502 B1 EP2080502 B1 EP 2080502B1 EP 08100536 A EP08100536 A EP 08100536A EP 08100536 A EP08100536 A EP 08100536A EP 2080502 B1 EP2080502 B1 EP 2080502B1
Authority
EP
European Patent Office
Prior art keywords
conductor path
blister pack
cavity
conductor
onto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP08100536A
Other languages
German (de)
English (en)
Other versions
EP2080502A1 (fr
Inventor
Ulrich Moosheimer
Wolfgang Neft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schreiner Group GmbH and Co KG
Original Assignee
Schreiner Group GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schreiner Group GmbH and Co KG filed Critical Schreiner Group GmbH and Co KG
Priority to AT08100536T priority Critical patent/ATE534365T1/de
Priority to EP08100536A priority patent/EP2080502B1/fr
Priority to PCT/EP2009/000177 priority patent/WO2009090048A1/fr
Priority to EP09701699.2A priority patent/EP2242469B1/fr
Publication of EP2080502A1 publication Critical patent/EP2080502A1/fr
Application granted granted Critical
Publication of EP2080502B1 publication Critical patent/EP2080502B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035Blister-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00General characteristics or adaptations
    • A61J2200/30Compliance analysis for taking medication

Definitions

  • the present invention relates to blister pack assemblies with a blister pack having cavities for receiving one drug dose each - such as in the form of a tablet, a pill or a dragee - and a closure foil, each dose of medicament being pushable out by depressing the associated cavity for removal through the closure foil, in particular blister pack arrangements which additionally have a conductor carrier which has a conductor track and is aligned relative to the cavities of the blister pack such that the conductor path can be pressed out by at least one surface defined by vertical projection of one of the cavities onto the conductor carrier, by which the medicament dose of this cavity can be pressed out for removal is, runs, so that the trace is interrupted by pushing out this drug dose through this area.
  • a completely separate interconnect loop can be provided for each cavity; or via each surface defined by vertical projection of one of the cavities on the conductor carrier, a branch of a parallel connection opens in two connections, and the number of withdrawn drug cans can be determined from the total resistance of the parallel connection whose reciprocal equals the sum of the reciprocals of the individual resistances of all intact branches is.
  • the conductor carrier which consists of a flat material, such as a plastic film or a multilayer film composite.
  • the conductor carrier can in turn be glued to the sealing film of the blister pack.
  • a self-adhesive design of the conductor carrier is customary, which is presented on a sheet-like release material and then, usually mechanically, is applied to the sealing film of the blister pack.
  • a Blisterpackungsanordung of the type mentioned is from the German patent application DE 10 2004 060 213 A1 known.
  • Blisterpackungsanordung defined by vertical projection of one of the cavities on the conductor carrier surface is in each case surrounded annularly by punching lines.
  • the punched lines are interrupted by two formed from the flat material of the conductor carrier narrow web portions over which the conductor tracks out become.
  • this object is achieved by avoiding the tearing of a web part on the circumference of the surface defined by vertical projection of one of the cavities onto the conductor carrier.
  • the solution of the problem with a blister pack assembly according to claim 1 is implemented.
  • the rupture of a web portion on the circumference of the area defined by vertical projection of one of the cavities on the conductor carrier surface is avoided here, that the web part to be cut is moved into the surface defined by vertical projection of the cavity on the conductor carrier.
  • Compared to the conventional design of a web portion at the edge of the plane defined by vertical projection of the cavity on the conductor carrier surface results in more favorable force introduction conditions, which can tear the web part easier.
  • Punching lines can basically be provided both in the form of simple punched lines, as well as in the form of gap-like recesses.
  • any variant of the invention described or indicated in the context of the present application may be particularly advantageous, depending on the economic and technical conditions in the individual case.
  • individual features of the described embodiments are interchangeable or can be combined with one another and also with measures known per se from the prior art.
  • Fig. 1 the conductor carrier of a blister pack assembly according to the invention is shown in plan view.
  • stamping image of the Medication removal facilitating punching lines 3 summarized in a representation.
  • gap-like recesses can also be provided in partial areas. At the edge numbers are given from 1.1 to 1.10 for easier reference to the individual variants.
  • a common punching pattern will usually be selected for each drug dose to be withdrawn.
  • a desired conductor track guidance can allow the person skilled in the art also to take individualized punched images, for example for cavities 7 arranged at the corners of the blister pack.
  • the conductor carrier is made of a flat material 4, which may be, for example, a plastic film (PET, PE, PP, PVC, PA ...), a film composite or paper.
  • the conductor tracks 1 are printed on the flat material 4.
  • Each cavity 7 is assigned its own conductor loop. Whether this is consistent, about the in Fig. 1 not detailed executed connections are queried at the edge of the conductor carrier shown below. For each cavity 7, a separate connection is provided so that it can be detected from which cavity 7 the drug dose contained therein was taken.
  • the printed conductors 1 and their connections can be carried out essentially as known from the prior art.
  • the conductor 1 is guided via a centrally arranged in the plane defined by vertical projection of the associated cavity 7 on the conductor carrier surface web portion 2.
  • the web part 2 is formed from the flat material 4 and defined by punched lines 3.
  • the narrow interruption of a punching line (as shown in FIG. 4, bottom row) is already to be understood as a web part 2; in the embodiments of Fig. 1
  • the web part 2 is extended in each case by Stanzlinienfort accounts, which makes the web part 2 easier to tear.
  • the web part 2 may be further weakened by punching
  • the branching of the punching lines 3 also facilitates the tearing open of the flat material 4 in the region of the associated cavity 7 when the tablet, pill or tablet arranged in the cavity 7 is pushed out of the cavity 7 by pressure on the cavity 7.
  • the introduction of force is particularly favored by the fact that the web part 2 interrupts a punching line 3 which divides the surface defined by vertical projection of the associated cavity 7 on the strip carrier approximately into two halves (upper and lower in the illustration).
  • the punched lines 3 can lie completely within the area defined by vertical projection of the associated cavity 7 on the strip conductor carrier (variants 1.1 to 1.9), and also extend beyond them (variant 1.10).
  • Fig. 2 shows two embodiments in a representation.
  • the guidance of the conductor 1 via web portions 2 is provided.
  • the web parts 2 are not extended by punching line extensions, which simplifies the stamping image.
  • Particularly favorable for the introduction of force is the arrangement of the punching lines 3 such that they approximately halve the areas defined by vertical projection of the associated cavities 7 on the conductor carrier.
  • no pier sections 3 interrupting the piercing line 3 are provided.
  • the conductor 1 crosses the punching line directly, which is no longer the subject of the invention.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Claims (7)

  1. Dispositif d'emballage du type blister, présentant
    - un emballage du type blister, lequel présente des cavités (7) servant à loger chacune une dose de médicament ainsi qu'une feuille d'obturation, chaque dose de médicament pouvant être extraite à travers la feuille d'obturation par enfoncement de la cavité (7) afférente pour le prélèvement,
    - un support de piste conductrice, lequel présente une piste conductrice (1) et est orienté de telle manière par rapport aux cavités (7) de l'emballage du type blister que la piste conductrice (1) passe par au moins une surface qui est définie par projection verticale d'une des cavités sur le support de piste conductrice et par laquelle la dose de médicament de cette cavité (7) peut être extraite pour le prélèvement, de sorte que la piste conductrice (1) puisse être interrompue par extraction de cette dose de médicament à travers cette surface,
    - la piste conductrice (1) pouvant être interrompue par extraction de la dose de médicament à l'intérieur de la surface définie par projection verticale de la cavité (7) sur le support de piste conductrice,
    - la piste conductrice (1) passant par une partie âme (2) définie au moyen de lignes de poinçonnage (3) et disposée à l'intérieur de la surface définie par projection verticale de la cavité (7) sur le support de piste conductrice, de sorte que la piste conductrice puisse être interrompue par destruction de la partie âme (2) par extraction de la dose de médicament à travers cette surface,
    caractérisé en ce qu'au moins une ligne de poinçonnage (3) passant à l'intérieur de la surface définie par projection verticale de la cavité (7) sur le support de piste conductrice est ramifiée.
  2. Dispositif d'emballage du type blister selon la revendication 1, où les lignes de poinçonnage (3) définissant la partie âme (2) passent entièrement à l'intérieur de la surface définie par projection verticale de la cavité (7) sur le support de piste conductrice.
  3. Dispositif d'emballage du type blister selon la revendication 1, où les lignes de poinçonnage (3) définissant la partie âme (2) passent en partie en dehors de la surface définie par projection verticale de la cavité (7) sur le support de piste conductrice.
  4. Dispositif d'emballage du type blister selon l'une des revendications 1 à 3, où la partie âme (2) interrompt une ligne de poinçonnage (3) qui répartit la surface définie par projection verticale de la cavité (7) sur le support de piste conductrice en surfaces partielles présentant un rapport de surface de 1:1 à 1:3 entre elles.
  5. Dispositif d'emballage du type blister selon l'une des revendications 1 à 4, où la partie âme (2) interrompt une ligne de poinçonnage (3) et se prolonge par des appendices de ligne de poinçonnage passant en travers par rapport à la ligne de poinçonnage (3) interrompue.
  6. Dispositif d'emballage du type blister selon l'une des revendications précédentes, où le support de piste conductrice présente plusieurs pistes conductrices (1).
  7. Dispositif d'emballage du type blister selon la revendication 6, où des pistes conductrices (1) sont, au moins à un endroit, guidées en plusieurs nappes et où une couche isolante est prévue au niveau du guidage des pistes conductrices en plusieurs nappes afin d'isoler des pistes conductrices (1) se chevauchant l'une l'autre.
EP08100536A 2008-01-16 2008-01-16 Dispositif d'emballage du type blister Active EP2080502B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AT08100536T ATE534365T1 (de) 2008-01-16 2008-01-16 Blisterpackungsanordung
EP08100536A EP2080502B1 (fr) 2008-01-16 2008-01-16 Dispositif d'emballage du type blister
PCT/EP2009/000177 WO2009090048A1 (fr) 2008-01-16 2009-01-14 Système d'emballage-coque
EP09701699.2A EP2242469B1 (fr) 2008-01-16 2009-01-14 Dispositif d'emballage du type blister

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08100536A EP2080502B1 (fr) 2008-01-16 2008-01-16 Dispositif d'emballage du type blister

Publications (2)

Publication Number Publication Date
EP2080502A1 EP2080502A1 (fr) 2009-07-22
EP2080502B1 true EP2080502B1 (fr) 2011-11-23

Family

ID=39467197

Family Applications (2)

Application Number Title Priority Date Filing Date
EP08100536A Active EP2080502B1 (fr) 2008-01-16 2008-01-16 Dispositif d'emballage du type blister
EP09701699.2A Active EP2242469B1 (fr) 2008-01-16 2009-01-14 Dispositif d'emballage du type blister

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP09701699.2A Active EP2242469B1 (fr) 2008-01-16 2009-01-14 Dispositif d'emballage du type blister

Country Status (3)

Country Link
EP (2) EP2080502B1 (fr)
AT (1) ATE534365T1 (fr)
WO (1) WO2009090048A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103413206A (zh) * 2013-08-28 2013-11-27 上海爱信诺航芯电子科技有限公司 一种适用于药板管理的智能rfid药板系统
AU2011315317B2 (en) * 2010-10-14 2015-01-22 Future Technology (Uk) Ltd Seals

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011018199A1 (de) * 2011-04-19 2012-10-25 Schreiner Group Gmbh & Co. Kg Detektionselement für eine Blisterverpackung und Blisterverpackungseinheit
US10930383B2 (en) 2015-07-03 2021-02-23 Cuepath Innovation Inc. Connected sensor substrate for blister packs
EP3316847B1 (fr) * 2015-07-03 2020-05-06 Cuepath Innovation Inc. Substrat de capteur connecté pour emballages-coques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015857A1 (fr) * 2001-08-16 2003-02-27 Meridica Limited Emballage contenant un medicament et dispositif distributeur
WO2009143234A1 (fr) * 2008-05-22 2009-11-26 Wm. Wrigley Jr. Company Protection d’emballage-coque à double incision au laser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5412372A (en) * 1992-09-21 1995-05-02 Medical Microsystems, Inc. Article dispenser for monitoring dispensing times
ES2253617T3 (es) 2003-08-14 2006-06-01 SCHREINER GROUP GMBH & CO. KG Etiqueta.
DE502004005343D1 (de) 2003-12-19 2007-12-06 Simon Udo Blisterpackungsanordnung
US6973371B1 (en) * 2004-10-13 2005-12-06 Nadir Benouali Unit dose compliance monitoring and reporting device and system
WO2007138520A1 (fr) * 2006-05-30 2007-12-06 Nxp B.V. Emballage-coque électronique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015857A1 (fr) * 2001-08-16 2003-02-27 Meridica Limited Emballage contenant un medicament et dispositif distributeur
WO2009143234A1 (fr) * 2008-05-22 2009-11-26 Wm. Wrigley Jr. Company Protection d’emballage-coque à double incision au laser

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011315317B2 (en) * 2010-10-14 2015-01-22 Future Technology (Uk) Ltd Seals
CN103413206A (zh) * 2013-08-28 2013-11-27 上海爱信诺航芯电子科技有限公司 一种适用于药板管理的智能rfid药板系统
CN103413206B (zh) * 2013-08-28 2016-06-29 上海爱信诺航芯电子科技有限公司 一种适用于药板管理的智能rfid药板系统

Also Published As

Publication number Publication date
EP2242469A1 (fr) 2010-10-27
EP2242469B1 (fr) 2016-05-04
EP2080502A1 (fr) 2009-07-22
WO2009090048A1 (fr) 2009-07-23
ATE534365T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
DE69835292T2 (de) Vorrichtung zur detektierung einer arzneimittelabgabe
DE10213547C1 (de) Blisterpackungsanordnung
EP1737750B1 (fr) Dispositif d'emballage a blister
EP1947027B1 (fr) Habillage transparent et procédé de stockage temporaire de produits
EP2059455B1 (fr) Emballage pour films contenant une substance active, et son procédé de fabrication
EP2080502B1 (fr) Dispositif d'emballage du type blister
EP1838595B1 (fr) Emballage en feuilles
DE3004637A1 (de) Verfahren zur ausstattung von durchdrueckpackungen mit haftetiketten
EP1353857B1 (fr) Unite d'emballage primaire destinee a plusieurs comprimes pellicules individuels en tant que formes pharmaceutiques
WO2011076789A1 (fr) Contenant constitué de feuilles d'un blister ne pouvant pas être ouvert par application d'une pression
DE3317549A1 (de) Geraet zum entnehmen von kapseln, tabletten oder dragees aus folienpackungen (blister)
EP1474090B1 (fr) Systeme pour detecter au moyen d'un dispositif electronique le retrait de produits d'un emballage
EP1911378A1 (fr) Procédé de fabrication d'un emballage
DE102020126301A1 (de) Blisterkarte zur Verblisterung von Medikamenten und Verfahren zum Verteilen von Medikamenten mittels einer Blisterkarte
EP2475592B1 (fr) Étiquette de protection destinée à protéger des médicaments contenus dans un emballage individuel
DE19957809B4 (de) Verwendung einer Blisterpackung
EP1985550A1 (fr) Unité d'emballage pour médicament et son procédé de fabrication
DE102013107410A1 (de) Mehrlagiges Etikett
DE202008017320U1 (de) Peel-Push-Blisterverpackung
WO2022268470A1 (fr) Dispositif d'étiquetage et procédé de fabrication d'un dispositif d'étiquetage pour une seringue, et système de seringue
DE202011004393U1 (de) Versiegelungsanordnung für Blisterverpackungen
DE102011082207A1 (de) Blisterverpackung
DE1958477U (de) Verpackungsstrang fuer durchdrueckpackungen zur aufnahme von trabletten od. dgl.
DE19945532A1 (de) Behältnis, insbesondere Behältnisse für fließfähige Mittel
DE8805777U1 (de) Handschuh-Inserts-Bevorratungseinheit

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

17P Request for examination filed

Effective date: 20091211

17Q First examination report despatched

Effective date: 20100118

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: FREI PATENTANWALTSBUERO AG

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502008005645

Country of ref document: DE

Effective date: 20120216

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120323

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120323

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120223

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120131

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

26N No opposition filed

Effective date: 20120824

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502008005645

Country of ref document: DE

Effective date: 20120824

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120116

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080116

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: NEW ADDRESS: POSTFACH, 8032 ZUERICH (CH)

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20200121

Year of fee payment: 13

Ref country code: IE

Payment date: 20200122

Year of fee payment: 13

Ref country code: NL

Payment date: 20200122

Year of fee payment: 13

Ref country code: IT

Payment date: 20200122

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20200127

Year of fee payment: 13

Ref country code: BE

Payment date: 20200122

Year of fee payment: 13

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20210201

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 534365

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210116

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210116

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210116

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210116

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230515

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250120

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20250123

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20250123

Year of fee payment: 18